Evolent stock tumbles 34% post-market on Q3 report, lowered guidance

jurgenfr Shares of Evolent Health ( NYSE: EVH ) tumbled 34% post-market Thursday after the healthcare company released a Q3 earnings report that fell short of Street estimates and lowered its 2024 guidance. While Evolent’s ( EVH ) Q3 revenue increased 21.6% year-over-year to $621.

4M, it still fell.